Based on recent data, Sarepta Therapeutics, Inc. (SRPT) shows an Average True Range (ATR) of 1.16 and an Enterprise Value of 12.63B. Its average trading volume over the past 3 months is 3.16M, indicating liquidity. These fundamental metrics provide insight into SRPT's underlying financial health and market activity.
| ATR | 1.16 |
| Enterprise Value | 12.63B |
| Avg Vol (3 Months) | 3.16M |
| Avg Vol (10 Days) | 3.21M |
Sarepta Therapeutics, Inc. (SRPT) technical indicators as of July 9, 2026: the SMA 20 is -6.87%, SMA 50 at -15.15%, and SMA 200 at -20.03%. The RSI 14 value is 39.24, suggesting its current momentum. These technical analysis signals help assess SRPT's price trends and potential future movements.
| SMA 20 | -6.87% |
| SMA 50 | -15.15% |
| SMA 200 | -20.03% |
| RSI 14 | 39.24 |
Sarepta Therapeutics, Inc. (SRPT) stock performance overview as of July 9, 2026: The 52-week high is $25.32 (currently -84.07% below), and the 52-week low is $10.42 (currently 67.55% above). Over the past year, SRPT's performance is -82.03%, compared to the S&P 500's 6.09% change.
| 52-Week High | 25.32 |
| 52-Week High Chg | -84.07% |
| 52-Week Low | 10.42 |
| 52-Week Low Chg | +67.55% |
| S&P 500 52-Week Chg | 6.09% |
According to market data, Sarepta Therapeutics, Inc. (SRPT) stock's recent performance metrics show that over the last month, SRPT is -0.47%, with a Year-to-Date (YTD) performance of -2.23%. Over the past year, the stock has seen a -82.03% change. These figures summarize SRPT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 20.3 | 20.3 | 23.84 | 24.68 | 25.32 | 24.68 |
| Low | 17.45 | 14.68 | 14.68 | 14.68 | 10.42 | 14.68 |
| Performance | -0.47% | -0.47% | -6.53% | +57.96% | -82.03% | -2.23% |
According to current financial data, SRPT stock's P/E (TTM) ratio is 32.00, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for SRPT, including P/S (0.96), P/B (1.38), and P/FCF (19.74), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | SRPT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 32 | -1.22 | -194.02 | 32.59 |
| P/S (TTM) | 0.96 | 3.68 | 466.98 | 5.98 |
| P/B (TTM) | 1.38 | -0.1 | 11.17 | 5.13 |
| P/FCF (TTM) | 19.74 | 352.33 | -624.73 | 29.02 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep